Chemical Safety Evaluation & Testing

Toxicity Evaluation Support

Toxicological data interpretation and OEL derivation

What this study delivers

Toxicity Evaluation
Support

Toxicity evaluation services interpret laboratory and literature toxicity data to support GHS classification, OEL derivation, and risk-based design. We bridge toxicology, industrial hygiene, and process safety to deliver actionable safe-use guidance.

Toxicity Evaluation Support — Overview
Study execution

How the study is executed

A structured, facilitated process — from scope definition through close-out — producing defensible, actionable outputs.

Hazard Identification & Endpoint Selection

Identify toxicity endpoints per ECHA / OECD — acute (oral, dermal, inhalation LD50/LC50), skin/eye irritation, sensitisation, repeated-dose, mutagenicity, carcinogenicity, reproductive; align with REACH Annex VII-X tiered requirements.

Acute & Subchronic Testing

Conduct acute toxicity per OECD 401-405 (replaced by 420/423/425), subchronic per OECD 407-408; specify GLP (Good Laboratory Practice) compliance per OECD GLP Principles; align with REACH / CLP / GHS.

In-Vitro & QSAR Alternatives

Apply in-vitro alternatives per OECD validated methods — skin irritation (OECD 439), eye irritation (OECD 491/492), sensitisation (OECD 442C/D/E); apply QSAR per OECD QSAR Toolbox to reduce animal testing.

Exposure Assessment & OEL Setting

Conduct exposure assessment per ECETOC TRA / ChEM / ART; derive Occupational Exposure Limit per ACGIH / DECOS / SCOEL methodology; align with REACH DNEL derivation and OSHA PEL framework.

Workplace Exposure & Health Surveillance

Design workplace exposure monitoring per EN 689 / NIOSH 1995; specify health surveillance per occupational medicine guidance — biological monitoring, audiometry, spirometry; align with OSHA / EU regulatory programmes.

Toxicity Dossier & SDS Integration

Compile toxicity dossier with test reports, exposure assessment, and risk characterisation; integrate with REACH dossier, CLP / GHS classification, SDS authoring; align with corporate product stewardship programme.

Toxicity Evaluation Support — Scope
Study scope

What the study covers in full

Acute, chronic, and target-organ toxicity review
OEL derivation (ACGIH-style methodology)
DNEL/DMEL calculation per REACH
GHS health hazard classification
Read-across and grouping justification
Risk-based exposure scenario development
Safe-use guidance for SDS Section 8/11
Why it matters

Outcomes of Toxicity Evaluation Support

Worker & Community Toxic Dose Reduction
  • Defines defensible OELs for novel chemicals
  • Fortifies industrial hygiene control design
  • Supports informed substitution decisions
  • Reduces chronic occupational illness risk
REACH / GHS / OSHA PEL Toxicity Defence
  • Maintains alignment with REACH DNEL/DMEL requirements
  • Supports GHS classification
  • Documents OEL derivation for inspectors
  • Withstands worker compensation scrutiny
OEL Setting & Health Surveillance Quality
  • Targets industrial hygiene controls effectively
  • Strengthens SDS Section 8/11 content
  • Supports MOC for new chemical introductions
  • Informs medical surveillance triggers
Toxicity Exposure Liability Cost Prevention
  • Avoids over-protective PPE programmes
  • Reduces occupational disease liability
  • Supports premium pricing on lower-hazard products
  • Optimises industrial hygiene investment
Get Started

Ready to start your project?

Speak with our team to scope an engagement tailored to your facility, regulatory context, and lifecycle stage.